Franco-Cereceda A, Nagata M, Svensson T H, Lundberg J M
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Eur J Pharmacol. 1987 Oct 13;142(2):267-73. doi: 10.1016/0014-2999(87)90116-6.
The effects of treatment with reserpine and/or the selective alpha 2-adrenoreceptor agonists clonidine and oxymetazoline on tissue levels of neuropeptide Y (NPY)-like immunoreactivity (-LI) and noradrenaline (NA) were studied in the guinea-pig. Clonidine treatment was associated with an increase in the levels of NPY-LI in the right atrium in a time- and dose-dependent manner. A significant (45%) elevation of the right atrial content of NPY-LI was present 2 h after administration of clonidine (50 micrograms kg-1 s.c.). After 24 h of repeated clonidine treatment the atrial levels of NPY-LI had increased by 95%. Following chronic clonidine treatment for two weeks, however, the right atrial NPY levels were similar to those in control animals. The corresponding cell-body content of NPY-LI in the stellate ganglion, remained unaffected by clonidine treatment. The levels of NPY-LI were also increased in the gastrocnemius muscle, spleen and adrenal gland after clonidine treatment while no changes were detected in the vas deferens or hypothalamus. The reserpine-induced reduction of NPY-LI in the right atrium, spleen, gastrocnemius muscle and adrenal gland was markedly inhibited by concomitant clonidine treatment while no effect was observed on NA depletion. The adrenoreceptor antagonists phentolamine, prazosin and yohimbine all inhibited the increase in cardiac content of NPY-LI seen after clonidine treatment. No elevation of tissue content of NPY-LI was observed after oxymetazoline (50 micrograms kg-1 s.c.) which, however, reversed the reserpine-induced depletion of NPY-LI. The reserpine-induced increase in content of NPY-LI in the stellate ganglion was also inhibited by clonidine and oxymetazoline.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了利血平及/或选择性α₂ - 肾上腺素能受体激动剂可乐定和羟甲唑啉对豚鼠组织中神经肽Y(NPY)样免疫反应性(-LI)和去甲肾上腺素(NA)水平的影响。可乐定治疗与右心房中NPY - LI水平的升高呈时间和剂量依赖性。给予可乐定(50微克/千克皮下注射)2小时后,右心房NPY - LI含量显著升高(45%)。重复给予可乐定24小时后,心房NPY - LI水平升高了95%。然而,在慢性可乐定治疗两周后,右心房NPY水平与对照动物相似。星状神经节中相应的NPY - LI细胞体含量不受可乐定治疗的影响。可乐定治疗后,腓肠肌、脾脏和肾上腺中NPY - LI水平也升高,而在输精管或下丘脑未检测到变化。同时给予可乐定可显著抑制利血平引起的右心房、脾脏、腓肠肌和肾上腺中NPY - LI的降低,而对NA耗竭无影响。肾上腺素能受体拮抗剂酚妥拉明、哌唑嗪和育亨宾均抑制可乐定治疗后心脏NPY - LI含量的增加。羟甲唑啉(50微克/千克皮下注射)后未观察到组织中NPY - LI含量升高,但其可逆转利血平引起的NPY - LI耗竭。可乐定和羟甲唑啉也抑制了利血平引起的星状神经节中NPY - LI含量的增加。(摘要截短于250字)